Stay updated with breaking news from Ability Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug ABTL0812 in pancreatic cancer patients.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
"Pancreatic Cancer Treatment Market"(Albany, USA) DelveInsight's "Pancreatic Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Pancreatic Cancer, historical and
The prevalence of pancreatic cancer has been rising since the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cancer, the robust pipeline
Pancreatic Cancer Pipeline is enriched with novel therapeutic strategies, including a broad range of therapies targeting diverse biologic processes. The...